Ruxolitinib sensitizes ovarian cancer to reduced dose...

Oncotarget 2017 / 11 Vol. 8; Iss. 55

Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice

Reeves, Patrick M., Abbaslou, Mojgan A., Kools, Farah R.W., Vutipongsatorn, Kritchai, Tong, Xiaoyun, Gavegnano, Christina, Schinazi, Raymond F., Poznansky, Mark C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.21541
Date:
November, 2017
File:
PDF, 4.58 MB
english, 2017
Conversion to is in progress
Conversion to is failed